Navigation Links
Psoriasis Cure Now Welcomes Institute of Medicine Report Urging 'Comparative Effectiveness' Research on Psoriasis, But Worries About Risk of Rationing
Date:6/30/2009

KENSINGTON, Md., June 30 /PRNewswire-USNewswire/ -- "Psoriasis Cure Now," a nonprofit patient advocacy group, today applauded the Institute of Medicine (IOM) for including psoriasis and psoriatic arthritis among its Top 100 health topics meriting priority "comparative effectiveness" research, but the organization expressed concern that treatment rationing could result from the research.

The IOM included the use of biologics for treating inflammatory diseases including psoriatic arthritis among its top ("First Quartile") priorities for the first round of comparative effectiveness research, and included comparing the effectiveness of various treatments for psoriasis among its Second Quartile priorities. According to the IOM, "A committee convened by the IOM developed the list of priority topics at the request of Congress as part of a $1.1 billion effort to improve the quality and efficiency of health care through comparative effectiveness research outlined in the American Recovery and Reinvestment Act of 2009."

"We applaud the IOM committee for including treatments for psoriasis and psoriatic arthritis among its priority research areas, as it can be very challenging for patients with these lifelong diseases to navigate their myriad treatment options, each of which has its own set of short and long-term risks," said Michael Paranzino, president of Psoriasis Cure Now. "But as with most things in life, the devil is in the details. Comparative effectiveness research requires assigning extremely controversial dollar amounts to various levels of patient improvement, and also assigns monetary values to various levels of risk of side-effects, even though a 25 year-old mother and a 70 year-old man might have very different levels of willingness to risk serious side-effects. Today's comparative effectiveness research can very easily become tomorrow's rationing mandate."

Paranzino continued, "Different psoriasis treatments vary widely in cost, effectiveness, and side-effects. Some patients will trade less effectiveness for fewer side-effects. Others will accept serious long-term risks to feel better now. In addition, some psoriasis treatments cause catastrophic birth defects if given to women who become pregnant while taking them, but help men without these risks. In short, for a researcher to conclude that Treatment A helps an 'average' patient improve for less money than Treatment B, that researcher must make assumptions that may fly in the face of reality for real patients in real-world circumstances.

"It is essential that patient voices be heard throughout the actual comparative effectiveness research, or else this could become just a fancy way to deny advanced, but costly, treatments to people with serious but incurable diseases like psoriasis."

For more information on psoriasis, visit the Psoriasis Cure Now homepage at http://www.psoriasis-cure-now.org.


'/>"/>
SOURCE Psoriasis Cure Now
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New Source of Information on Psoriasis Medications
2. Psoriasis Raises Risk of Heart Attack, Stroke, Death
3. American Academy of Dermatology Issues New Guidelines For the Management of Psoriasis With Systemic Medications
4. Psoriasis Patients Happy With Home-Based Treatment
5. Study Results Published in CUTIS Demonstrate Long-Term Safety and Efficacy of Vectical(TM) (calcitriol) Ointment 3 mcg/g in the Management of Mild-to-Moderate Plaque Psoriasis
6. Having Psoriasis Raises Risk of Diabetes, Hypertension
7. Psoriasis Drug Raptiva Pulled From U.S. Market
8. Low-Dose Acitretin May Reduce Nail Psoriasis
9. BioTrends Prepares to Field ChartTrends(TM) Reports to Cover the Use of Biologic Agents in Psoriasis and Rheumatoid Arthritis
10. LeAnn Rimes Shares Her Personal Struggle With Psoriasis in Nations Capital
11. Study Shows Nonprescription LCD Topical Solution is More Effective than Prescription-Strength Calcipotriol Cream for Moderate Plaque Psoriasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... ... September 25, 2017 , ... Nissar A. Darmani, PhD, has been ... patients suffering from chemotherapy-evoked nausea and vomiting. Dr. Darmani is Associate Dean of ... , The five-year grant is from the National Cancer Institute (NCI) arm of the ...
(Date:9/25/2017)... ... ... Introducing Panther, the revolutionary new iPhone case engineered to stop bacteria growth ... support for the #WarOnGrime. , Fact: iPhones are 18 times dirtier than toilets. 1 ... Panther iPhone cases are the first weapon in the war on bacteria with innovative ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... development solutions for drugs, biologics and consumer health products, today announced that two ... and validation of bioassays at two upcoming conferences. , At the BEBPA 10th ...
(Date:9/25/2017)... ... 2017 , ... PITTSBURGH...An inventor, from Richmond Hill, Ga., thought there needed to ... facilities, so he invented the COMPLETE PATIENT CHART. , The COMPLETE PATIENT CHART provides ... offers an improved alternative to paper charts and clipboards. As a result, it increases ...
(Date:9/25/2017)... (PRWEB) , ... September 25, 2017 , ... METTLER TOLEDO ... place October 25-26, 2017 in Los Angeles, CA. The symposium will feature speakers from ... dealing with today's mass calibration technologies and help with planning for the future of ...
Breaking Medicine News(10 mins):
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform ... leadership team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led ...
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
(Date:9/12/2017)... 12, 2017  Consumer reviews on the independent review site ... number one company for hearing aids, ranking it higher than ... ... by Consumers For Hearing Aids ... is an online store that provides high performance, state-of-the-art, German-engineered hearing ...
Breaking Medicine Technology: